US equities |
NVDA $241.71 ▲+1.17% SPCX $173.76 ▲+1.56% MU $1,065.00 ▲+0.10% AMD $656.45 ▲+3.91% MRVL $291.61 ▲+7.50% SNDK $1,673.58 ▼-1.79% AVGO $378.42 ▲+4.39% TSLA $380.15 ▲+0.38%
FinancialContent

Latest News about Glymphatic

Recent news which mentions Glymphatic

NeuraWorx Partners with Corundum Neuroscience to Initiate Clinical Feasibility Study, Develop Innovative Neurological Disease Treatment
Tags Traumatic Brain Injury Health Defense
From PRLog